Monitoring tumor proliferative response to radiotherapy using 18F-fluorothymidine in human head and neck cancer xenograft in comparison with Ki-67

Annals of Nuclear Medicine

Volumn 27, Issue 4, 2013, Pages 355-362

  Fatema, Chowdhury Nusrat ^a,b   Zhao, Songji ^b   Zhao, Yan ^b   Murakami, Masahiro ^b,c   Yu, Wenwen ^a,b   Nishijima, Ken Ichi ^b   Tamaki, Nagara ^b   Kitagawa, Yoshimasa ^a   Kuge, Yuji ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Head and neck cancer xenograft; Ki 67 labeling index; Radiotherapy; Tumor proliferation

Indexed keywords

FLUORINE 18; MONOCLONAL ANTIBODY KI 67;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; CANCER RADIOTHERAPY; CONTROLLED STUDY; HEAD AND NECK CANCER; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE DISTRIBUTION; RADIATION MONITORING; RADIATION RESPONSE; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 84879111365     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-013-0693-9     Document Type: Article

References (33)

1. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet. 2008;371:1695-709.
2. Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51:571-8.
3. Maciejewski B, Withers HR, Taylor JM, Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. Int J Radiat Oncol Biol Phys. 1989;16:831-43.
4. Petersen C, Zips D, Krause M, Schöne K, Eicheler W, Hoinkis C, et al. Repopulation of FaDu human squamous cell carcinoma during fractionated radiotherapy correlates with reoxygenation. Int J Radiat Oncol Biol Phys. 2001;51:483-93.
5. Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27:131-46.
6. Corry J, Rischin D. Strategies to overcome accelerated repopulation and hypoxia - what have we learned from clinical trials? Semin Oncol. 2004;31:802-8.
7. Van de Wiele C, Lahorte C, Oyen W, Boerman O, Goethals I, Slegers G, et al. Nuclear medicine imaging to predict response to radiotherapy: a review. Int J Radiat Oncol Biol Phys. 2003;55:5-15.
8. Avril NE, Weber WA. Monitoring response to treatment in patients utilizing PET. Radiol Clin North Am. 2005;43:189-204.
9. Fornace AJ, Fuks Z, Weichselbaum RR, Milas L. Radiation therapy. In: Mendelsohn J, Howley PM, Israel MA, Liotta LA, editors. The molecular basis of cancer. Philadelphia: Saunders; 2001. p. 423-54.
10. Takahashi T, Nakano T, Oka K, Ando K. Transitional increase in growth fraction estimated by Ki-67 index after irradiation to human tumor in xenograft. Anticancer Res. 2004;24:107-10.
11. Mankoff DA, Shields AF, Krohn KA. PET imaging of cellular proliferation. Radiol Clin North Am. 2005;43:153-67.
12. Gerdes J. Ki-67 and other proliferation markers useful for immunohistochemical diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol. 1990;1:199-206.
13. Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000;182:311-22.
14. 18F] FLT uptake after chemotherapy: an experimental study. Eur J Nucl Med Mol Imaging. 2002;29:1462-9.
15. 18F] fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors. Eur J Nucl Med Mol Imaging. 2006;33:412-9.
16. 18F] FLT and positron emission tomography. Nat Med. 1998;4:1334-6.
17. 18F] fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography. Cancer Res. 2003;63:3791-8.
18. 18F-fluorothymidine for monitoring tumor response to radiotherapy and photodynamic therapy in mice. J Nucl Med. 2004;45:1754-8.
19. He Q, Skog S, Welander I, Tribukait B. X-irradiation effects on thymidine kinase (TK): I. TK1 and 2 in normal and malignant cells. Cell Prolif. 2002;35:69-81.
20. Schwartz JL, Tamura Y, Jordan R, Grierson JR, Krohn KA. Effect of p53 activation on cell growth, thymidine kinase-1 activity, and 3′-deoxy- 3′ fluorothymidine uptake. Nucl Med Biol. 2004;31:419-23.
21. 18F] fluoro-3′- deoxythymidine (FLT). Mol Imaging Biol. 2007;9:340-7.
22. 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med. 2005;46:675-82.
23. Brown RS, Leung JY, Fisher SJ, Frey KA, Ethier SP, Wahl RL. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma. I. Are inflammatory cells important? J Nucl Med. 1995;36:1854-61.
24. Rasey JS, Grierson JR, Wiens LW, Kolb PD, Schwartz JL. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells. J Nucl Med. 2002;43:1210-7.
25. Fowler JF. Rapid repopulation in radiotherapy: a debate on mechanism. The phantom of tumor treatment-continually rapid proliferation unmasked. Radiother Oncol. 1999;122:156-8.
26. Wong CS, Hill RP. Experimental radiotherapy. In: Tannock IF, Hill RP, editors. The basic science of oncology. New York: McGraw-Hill; 1998. p. 322-34926.
27. Elledge SJ. Cell cycle checkpoints: preventing an identity crisis. Science. 1996;274:1664-72.
28. Wither HR. Radiation biology and treatment option in radiation oncology. Cancer Res. 1999;59:1676s-84s.
29. Koutsimpelas D, Brieger J, Kim DW, Stenzel M, Hast J, Mann WJ. Proangiogenic effects of ionizing irradiation on squamous cell carcinoma of the hypopharynx. Auris Nasus Larynx. 2008;35:369-75.
30. Valente G, Orecchia R, Gandolfo S, Arnaudo M, Ragona R, Kerim S, et al. Can Ki-67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma? J Clin Pathol. 1994;47:109-12.
31. Pan MH, Huang SC, Liao YP, Schaue D, Wang CC, Stout DB, et al. FLT-PET imaging of radiation responses in murine tumors. Mol Imaging Biol. 2008;10:325-34.
32. Raymond D. Stalking HIV immune dysregulation. GMHC Treat Issue. 2002;16:4-14.
33. Zhao S, Kuge Y, Kohanawa M, Takahashi T, Kawashima H, Temma T, et al. Extensive FDG uptake and its modification with corticosteroid in a granuloma rat model: an experimental study for differentiating granuloma from tumors. Eur J Nucl Med Mol Imaging. 2007;34:2096-105.